Evidence map›Paper›PMID 27942356›Full record

ArticleJundishapur journal of microbiology2016

Rapid Detection of Rifampicin- and Isoniazid-Resistant

Leyla Sahebi, Khalil Ansarin, Amir Monfaredan, Safar Farajnia, Seiran Nili, Majid Khalili

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Jundishapur journal of microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. An updated systematic review and meta-analysis onIranian journal of basic medical sciences · 2021
    Review
  2. Multiwalled Carbon Nanotubes-CeONanomaterials (Basel, Switzerland) · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leyla SahebiPhD of Molecular Epidemiology, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran.
Khalil AnsarinPhD of Molecular Epidemiology, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran.
Amir MonfaredanDepartment of Hematology, Faculty of Medicine, Tabriz Branch, Islamic Azad University, Tabriz, IR Iran.
Safar FarajniaDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran.
Seiran NiliPhD Student of Epidemiology, Health Deputy, Kurdistan University of Medical Sciences, Sanandaj, IR Iran.
Majid KhaliliMedical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccurate and rapid detection of drug-resistant

objectivesThe aim of this study was to determine the frequency of common mutations leading to isoniazid (INH) and rifampicin (RMP) resistance. PATIENTS AND

methodsIn a cross-sectional study carried out in 2014, 90 patients with

resultsA total of 23 mutations were found in isolates among which, codon

conclusionsDetection of drug resistance associated with mutations through real-time PCR by melting analysis technique showed a high differentiating power. This technique had high concordance with the standard proportion test and MAS-PCR results.

Indexed as

Drug ResistanceMelt Curve TechniqueMycobacterium tuberculosisReal-Time PCR

Identifiers

PMID27942356
PMCPMC5136450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.